Hydrogen Sulfide Index: Estimating Your Gut's Sulfide-Producing Capacity

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This stool-based test analyzes your microbiome's DNA to estimate its capacity to produce hydrogen sulfide (H2S), a gas made by certain gut bacteria through pathways like sulfate reduction and cysteine degradation. Labs combine these signals into an index scaled against a reference population. Higher sulfide-producing capacity is associated with bloating, altered stool patterns, and gut discomfort, so the index may help clarify next steps for digestive health.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Estimating your gut's sulfide-producing capacity

The hydrogen sulfide index test analyzes DNA from your stool to estimate your microbiome’s capacity to generate hydrogen sulfide (H₂S), a gas produced by certain gut bacteria. Modern sequencing methods—such as 16S rRNA profiling or whole-metagenome sequencing—identify the organisms present and the genes they carry that can drive H₂S pathways, including dissimilatory sulfate reduction, taurine and sulfite metabolism, and cysteine degradation. Labs combine these signals into an index that approximates sulfide production potential relative to a reference population. Some clinical settings also measure H₂S on breath testing, but this index focuses on what your stool microbiome is capable of producing in the colon. Results reflect your current ecosystem rather than permanent traits.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why sulfide capacity matters for gut comfort

Why this matters: H₂S acts as a double-edged molecule in the gut. At low, regulated levels it functions as a signaling gas that can influence motility and mucosal blood flow. At higher levels, it can stress colon cells by interfering with their preferred fuel (butyrate), weaken the mucus barrier, and amplify inflammatory signaling. Research links microbial H₂S excess with symptoms like bloating and diarrhea and with conditions marked by mucosal irritation, though more study is needed to define precise thresholds. Understanding your H₂S potential helps connect the dots between microbes, diet, and gut comfort.

This test brings the biology into focus. Hydrogen sulfide is largely produced by sulfate-reducing bacteria (for example, Desulfovibrio and some Bilophila) and by other microbes that break down sulfur amino acids such as cysteine. Diet supplies the substrates: sulfur-rich proteins, certain food additives, and bile-acid–bound taurine can all feed these pathways. Stress, medication exposure, and recent infections can tilt the ecosystem in the same direction. When production potential runs high, people often describe “rotten egg” gas, cramping, urgency, or loose stools. When it runs lower, signaling effects may be muted, but symptoms usually hinge on the broader community balance. Testing can clarify whether an H₂S-heavy pattern is part of the story behind persistent GI complaints, especially after antibiotics, a major diet shift, or recurring post-meal discomfort.

The big picture: your microbiome is not just about digestion—it influences immune tone, barrier integrity, and even metabolic cues through short-chain fatty acids and other metabolites. Tracking your hydrogen sulfide index over time helps you see how real-world changes, like fiber quality, protein patterns, stress management, or recovery from illness, shape your microbial output. Think pattern recognition rather than perfection. The goal is to understand your signature and use that insight, alongside clinical input, to support long-term gut resilience.

Making sense of your index

Your report typically presents an H₂S potential score compared to a reference group, often summarized as low, moderate, or high, with context about the microbes and genes contributing to that score. Balanced patterns tend to pair a moderate sulfide potential with a healthy presence of beneficial butyrate producers (such as Faecalibacterium and Roseburia). Those butyrate producers help nourish colon cells and can buffer some effects of sulfide. In contrast, a higher index often reflects enrichment of sulfate reducers or increased pathways for cysteine and taurine degradation, along with a drop in diversity. Reference ranges vary by lab, and the index reflects potential, not an on-the-spot gas measurement.

What “optimal” means here is functional. A favorable profile supports efficient digestion, robust short-chain fatty acid production, a stable mucus barrier, and low inflammatory signaling. It’s common for people with steady, formed stools and minimal bloating to show moderate sulfide capacity within a diverse microbial community. Optimal ranges are not one-size-fits-all—they depend on your diet, geography, and genetics—which is why interpretation works best in context.

When the index is elevated, the pattern may signal a microbiome leaning into sulfur metabolism: more sulfate-reducing bacteria, more genes for sulfite and cysteine breakdown, and sometimes fewer protective butyrate producers. Functionally, excess sulfide can inhibit colonocyte use of butyrate, nudge the gut toward faster transit, and increase mucosal irritation. That does not diagnose a disease; it points to a functional direction that may align with symptoms like sulfurous gas, urgency, or post-meal cramping. Conversely, a very low index may indicate limited sulfur substrate or low abundance of sulfide-capable microbes. Extremely low signaling isn’t typically a problem by itself, but context matters—especially if diversity is also low.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What the index can and can't settle

Limitations and smart pairing: stool sequencing captures the colon ecosystem and its genetic capacity, not the real-time gas levels in your small intestine. Breath tests measure gases directly during a timed carbohydrate challenge but cover a different physiological question. Day-to-day variability, recent meals, supplements, and sample handling can shift results. That’s why trends matter more than a single snapshot. For the clearest picture, consider viewing your hydrogen sulfide index alongside stool inflammatory markers (such as calprotectin), short-chain fatty acids, bile acid patterns, or breath hydrogen/methane/H₂S if small-intestinal symptoms are prominent. Taken together with your history and current diet, these data help your care team translate the science into grounded, personalized next steps.

Frequently Asked Questions

References

  1. Blachier F, Andriamihaja M, Larraufie P, Ahn E, Lan A, Kim E (2021). Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa. *American Journal of Physiology-Gastrointestinal and Liver Physiology*, *320*(2), G125-G135. https://doi.org/10.1152/ajpgi.00261.2020
  2. Kushkevych I, Cejnar J, Treml J, Dordević D, Kollar P, Vítězová M (2020). Recent advances in metabolic pathways of sulfate reduction in intestinal bacteria. *Cells*, *9*(3), 698. https://doi.org/10.3390/cells9030698
  3. Mann ER, Lam YK, Uhlig HH (2024). Short-chain fatty acids: Linking diet, the microbiome and immunity. *Nature Reviews Immunology*, *24*(8), 577-595. https://doi.org/10.1038/s41577-024-01014-8
  4. Lynch SV, Pedersen O (2016). The human intestinal microbiome in health and disease. *New England Journal of Medicine*, *375*(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
  5. Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R (2019). Microbiome 101: Studying, analyzing, and interpreting gut microbiome data for clinicians. *Clinical Gastroenterology and Hepatology*, *17*(2), 218-230. https://doi.org/10.1016/j.cgh.2018.09.017

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey